课题基金 / 基金详情

LYME WESTERN BLOT INTERPRETIVE SOFTWARE

LYME WESTERN BLOT INTERPRETIVE SOFTWARE
莱姆蛋白质印迹解释软件
批准号:
2784254
负责人:
Andrew E. Levin
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 1999-08-31

项目摘要

项目成果

Andrew E. Levin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The development of software programs for the interpretation of Lyme Western Blots is proposed. The programs will analyze Western Blot band patterns scanned by a digital camera and interpret the test result as positive or negative. Two parallel, competing approaches will be taken: one based on statistical analysis of band data and the other on a neural network model. The statistical program will incorporate the CDC/ASTPHLD interpretive criteria for Lyme Western Blots, and will offer greater objectivity than a human interpreter. In contrast, the neural network program is capable of "learning" and improving its performance, and will develop its own criteria for interpretation through the analysis of large numbers of positive and negative samples. The neural network thus promises to surpass human accuracy in Lyme Western Blot interpretation, and provides a platform with which to develop interpretive capability for other diagnostic western blots. The program will be implemented on Immunetics' CodaVision(TM) analyzer, a fully automated instrument capable of performing 32 Western Blot assays in 30 minutes. This software program will resolve the issues of subjectivity, reader-to--reader inconsistency and interassay variability in the interpretation of Lyme Western Blots which have constrained their use as routine clinical tests. PROPOSED COMMERCIAL APPLICATIONS: The proposed software for interpretation of Lyme Western Blot tests will open this highly accurate technique to routine clinical laboratories which depend on automation to perform sophisticated tests. Offered together with Immunetics' CodaVision instrument, it will meet the growing demand for accurate Lyme disease testing. As the first such fully automated system on the market, it is anticipated that it will rapidly become the commercial standard for Lyme disease testing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Point-of-care diagnostic test for T. cruzi (Chagas) infection
  • 批准号:
    10603665
  • 项目类别:
  • 资助金额:
    $102.0万
  • 财政年份:
    2023
  • 负责人:
    Andrew E. Levin
  • 依托单位:
Development of an ELISA for serosurveillance of human hookworm
  • 批准号:
    10697222
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2023
  • 负责人:
    Andrew E. Levin
  • 依托单位:
Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
  • 批准号:
    9909230
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2020
  • 负责人:
    Andrew E. Levin
  • 依托单位:
Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
  • 批准号:
    10084274
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2020
  • 负责人:
    Andrew E. Levin
  • 依托单位:
海外基金